Novartis gets okay for SMA gene therapy, with $2m price tagAfter all the anticipation, Novartis has the FDA approval it has been seeking for Zolgensma, its gene therapy Share XNovartis gets okay for SMA gene therapy, with $2m price taghttps://pharmaphorum.com/news/novartis-gets-okay-for-sma-gene-therapy-with-2m-price-tag/
